1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Global Transdermal Drug Delivery Market to 2017: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

Global Transdermal Drug Delivery Market to 2017: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

  • December 2014
  • -
  • Kelly Scientific Publications
  • -
  • 280 pages

Summary

Table of Contents

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables & figures over 280 pages. This report is presented as follows:

- By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO)
- By Geography (Global, USA)
- By Parent Market (Drug Delivery Systems, Advanced Drug Delivery Systems)
- By Sub-market (Generics, Women’s Health, Analgesics, Neuropathic Pain)

A wealth of financial data & business strategy information is provided including:

- Up-to-date company financials, sales & revenue figures
- Revenue and market forecasts
- Business model strategies for drug delivery, pharmaceutical and biotechnology companies
- Comprehensive account of company products, financials & portfolios

SWOT, Economic & Regulatory Environment specifics include:

- Key strengths, weaknesses and threats influencing leading player position within the market
- Technologies driving the market (e.g., chemical enhancers, microneedles)
- Top fastest growing market segments and emerging opportunities
- Top pharmaceutical companies within the market
- Comprehensive product portfolios, R&D activity and pipeline products
- M&A activity and future strategies of top companies
- High demand and unmet need enhances the market
- Challenges of the transdermal drug delivery market

Who should read this report?
- Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
- Industry professionals and business strategists will discover key information to propel their policies
- Investors will gain inside information to dominant players in the industry and future forecasts
- Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment
C-Suite professionals, Decision Makers, Business Development professionals

This report will tell you if the companies mentioned are:
- Strong, competitive players
- Pooling their resources for specific growth and therapeutic areas
- Investing strategically in R&D
- Have a history of strategic M&A activity

This detailed report is supported with 320 figures and tables over 280 pages and profiles the main pharmacos in the transdermal drug delivery market.

Benefits of Investing in our Cutting-Edge Reports:

Clients receive complementary content* with mid-level and enterprise wide licences
Post-sale complementary consultation with senior expert analyst is included
Use of tables and figures in your own reports and presentations is permitted
Each report provides straight-talking strategic analysis & sector intelligence
All reports are updated each quarter to give you the most up-to-date information

WE WANT TO MAXIMIZE YOUR BUSINESS POTENTIAL
* Subject to terms & conditions negotiated with Kelly Scientific Publications prior to sale

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Taiwan Liposome Company Ltd (4152) - Financial and Strategic SWOT Analysis Review

Taiwan Liposome Company Ltd (4152) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Taiwan Liposome Company Ltd (TLC) is a biopharmaceutical company that research, develops and commercializes new pharmaceutical products based on drug delivery technologies. The company holds expertise ...

NanoCarrier Co Ltd (4571) - Financial and Strategic SWOT Analysis Review

NanoCarrier Co Ltd (4571) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary NanoCarrier Co Ltd (NanoCarrier) is a biotechnology company that researches, develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s research and development ...

NanoCarrier Co Ltd (4571) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NanoCarrier Co Ltd (4571) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary NanoCarrier Co Ltd (NanoCarrier) is a biotechnology company that researches, develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s research and development ...

Taiwan Liposome Co Limited

April 2017 $ 99

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.